U-73122, a phospholipase C inhibitor, impairs lymphocytic choriomeningitis virus virion infectivity
2024

U-73122 Impairs Lymphocytic Choriomeningitis Virus Infectivity

publication Evidence: moderate

Author Information

Author(s): Mizuma Keita, Hashizume Mei, Urata Shuzo, Shindo Keiko, Takashima Ayako, Mizuta Satoshi, Iwasaki Masaharu

Primary Institution: Osaka University

Hypothesis

Does U-73122 inhibit the multiplication of lymphocytic choriomeningitis virus (LCMV)?

Conclusion

U-73122 inhibits LCMV multiplication by impairing virion infectivity.

Supporting Evidence

  • U-73122 inhibited the production of infectious LCMV progeny.
  • U-73122 treatment resulted in a significant reduction of virally infected cells.
  • The compound showed a dose-dependent inhibitory effect on LCMV.
  • U-73122's antiviral activity was linked to its binding to a virion-associated molecule.

Takeaway

U-73122 is a compound that can stop a virus called LCMV from making more copies of itself, which could help in treating infections.

Methodology

The study used cell culture assays to test the effect of U-73122 on LCMV multiplication and virion infectivity.

Limitations

The short duration of U-73122's antiviral activity limits its potential as a treatment.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1099/jgv.0.002060

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication